Q3 2024 · 13F-HR
SILVERARC CAPITAL MANAGEMENT, LLCholdings as filed
Filed 2024-11-14 · accession 0001420506-24-002416
$445.3M
Reported value
71
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 670703107 | NUVL | NUVALENT INC | $38.0M | 8.53% | 371,441 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $31.7M | 7.13% | 635,439 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $25.4M | 5.70% | 347,695 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $21.8M | 4.91% | 475,555 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $19.0M | 4.26% | 6,946,488 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $18.4M | 4.12% | 639,840 | Common | SOLE |
| 92337F107 | VCYT | VERACYTE INC | $16.0M | 3.60% | 470,565 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $13.4M | 3.01% | 255,578 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $13.2M | 2.96% | 1,221,362 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $12.2M | 2.75% | 167,110 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $11.9M | 2.67% | 744,592 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $11.4M | 2.57% | 901,129 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $11.3M | 2.53% | 1,099,490 | Common | SOLE |
| 73730P108 | PSTXUSD | POSEIDA THERAPEUTICS INC | $10.5M | 2.37% | 3,687,548 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $10.0M | 2.25% | 348,866 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $9.8M | 2.21% | 35,774 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $8.2M | 1.84% | 1,801,561 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $7.3M | 1.64% | 378,746 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $6.9M | 1.55% | 60,500 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $6.7M | 1.49% | 574,558 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $6.6M | 1.48% | 146,657 | Common | SOLE |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $6.5M | 1.47% | 1,147,891 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $6.4M | 1.44% | 51,245 | Common | SOLE |
| 09075X108 | — | BIODESIX INC | $6.3M | 1.42% | 3,561,094 | Common | SOLE |
| 05479K106 | ELUT | ELUTIA INC | $6.3M | 1.41% | 1,645,808 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $5.7M | 1.27% | 1,795,080 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $5.6M | 1.25% | 5,645,352 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $5.4M | 1.22% | 455,082 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $5.4M | 1.20% | 513,369 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $5.3M | 1.19% | 461,660 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $5.1M | 1.16% | 627,552 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $5.1M | 1.15% | 103,862 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $5.0M | 1.12% | 99,566 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $4.9M | 1.11% | 145,000 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $4.1M | 0.93% | 124,353 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $3.9M | 0.87% | 19,940 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $3.9M | 0.87% | 67,045 | Common | SOLE |
| 60785L207 | — | MODULAR MED INC | $3.2M | 0.73% | 1,440,000 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $3.2M | 0.72% | 457,739 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $3.1M | 0.70% | 26,083 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $3.1M | 0.70% | 70,516 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $3.0M | 0.67% | 1,585,786 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $3.0M | 0.67% | 419,242 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $2.8M | 0.64% | 1,124,928 | Common | SOLE |
| M25722105 | CGEN | COMPUGEN LTD | $2.7M | 0.61% | 1,501,113 | Common | SOLE |
| 157085101 | CERS | CERUS CORP | $2.6M | 0.58% | 1,495,329 | Common | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $2.4M | 0.55% | 350,000 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $2.2M | 0.50% | 167,986 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $2.1M | 0.47% | 100,000 | Common | SOLE |
| 90466Y103 | — | UNICYCIVE THERAPEUTICS INC | $1.6M | 0.37% | 4,000,000 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $1.6M | 0.36% | 482,575 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $1.5M | 0.34% | 75,507 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $1.3M | 0.30% | 40,000 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $1.3M | 0.29% | 500,000 | Common | SOLE |
| M4119S187 | EVGN | EVOGENE LTD | $945,480 | 0.21% | 307,974 | Common | SOLE |
| 608550208 | MTEMEUR | MOLECULAR TEMPLATES INC | $876,492 | 0.20% | 623,838 | Common | SOLE |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $855,000 | 0.19% | 150,000 | CALL | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $850,000 | 0.19% | 100,000 | Common | SOLE |
| 92243A200 | VXRT | VAXART INC | $849,000 | 0.19% | 1,000,000 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $799,000 | 0.18% | 100,000 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $746,550 | 0.17% | 5,000 | Common | SOLE |
| 45783C200 | TIL | INSTIL BIO INC | $708,004 | 0.16% | 10,517 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $683,005 | 0.15% | 92,298 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $463,527 | 0.10% | 558,466 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $435,000 | 0.10% | 100,000 | Common | SOLE |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $421,665 | 0.09% | 166,666 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $367,214 | 0.08% | 17,800 | CALL | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $318,087 | 0.07% | 168,300 | CALL | SOLE |
| 01626L204 | ALGS | ALIGOS THERAPEUTICS INC | $227,057 | 0.05% | 26,219 | Common | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $144,354 | 0.03% | 76,784 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $6,761 | 0.00% | 104,828 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.